YOUR research produced a 95% on your investments in Newstrike, Zenabis, Hexo, Medmen and Nevada Copper.
I'm reasonably well informed on many cannabis stocks - the difference is that you rely on POwO Group and Tilray's own biased press releases - and I do actual drill down research.
I invest in US MSOs - and you invest in Tilray - a Canadian LP not allowed to be involved in the US cannabis market and wont be for years.
Why don't you just man up and quit w asting your fellow members time by simply posting your failed prediction?
Playing childish games doesn't do anyone much good - you hurt your own credibiltiy.
As far as my rambling on about a company 3 years ago on the Hexo board - you now agree that I was right with my identified company and unlike you - was man enough to share the name with fellow readers.
I dont actually promote too many stocks - I'm assuming you refer to Village Farms. I've been namimg VFF as one of the best long term investments in the cannabis sector - and one that is ripe for acquisition ...... by a US MSO as soon as legalziation or re-scheduling is official.
5 million sq ft of greenhouse in the US, ready to convert to cannabis the day after legalization, top 20 cbd retail in the US, facility in Netherlands and existing EU sales, a power company in Vancouver, commercial produce greenhouses in BC, hemp JVs in the US - partnerships in Mexico, Ontario and existing supply chains in the US along with a very good balance sheet.
Pure Sunfarms - VFFs cannabis dept - is one of the few profitable cannabis companies in North America - and had taken over the #1 market share spot from Tilray, (Tilray only reclaimed it by buying Hexo).
Village Farms owns Rose Lifescience - who in addition to their own product, markets,s ells and distributes Tilray/Hexo and CWEB products for them
Village Farms runs a lean, effcient operation - with 35 years of greenhouse growing experience
Listed on the Nasdaq (they gave up their TSX as an expensive listing for little value several years ago) - CEO Mike DeGiglo receives annual compensation of $1.1 million USD per year compared to Simple Simon's $30 million.
So quinlash - those few simple paragraphs above summarizing VFF is called FACTUAL research - I could go on at length.
Now why don't you name YOUR company and provide the same sort of analysis?
OR - as you now agree with me on VFF's value, just admit that YOUR research was stolen from mine, that Ive been posting for 3 years.
VFF is ripe for acquisition - DeGiglo doesn't deal with greasy snkae oil salesman like Simple Simon, IF theyre bought out - it'll be for a lot more than $250 million and it'll be by a US MSO.
I hope you can spitout whatever is in your throat making you cough.
Comment by
quinlashon Jul 02, 2024 9:49pm 
26 Views
Post# 36115617
RE:Tilray's Pending US News..
Keeler,
If it helps at all the company I am speculating on is one you yourself rambled on about about 3 years ago on the HEXO Forum
You should find it in your own post history.
Outside of that just give some thought to the US Fed restrictions, what Tilray would want in a company in order to facilitate higher sales and strong market share within the US then either exclude or consider each company that ties to cannabis.
It's called research, it's not going to hurt you in any manner.